Back to top
more

McKesson (MCK)

(Delayed Data from NYSE)

$525.28 USD

525.28
842,078

-0.66 (-0.13%)

Updated Nov 5, 2024 04:00 PM ET

Pre-Market: $535.02 +9.74 (1.85%) 9:10 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth D Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 31% (78 out of 251)

Industry: Medical - Dental Supplies

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

McKesson (MCK) Exceeds Market Returns: Some Facts to Consider

by Zacks Equity Research

McKesson (MCK) reachead $518.81 at the closing of the latest trading day, reflecting a +1.49% change compared to its last close.

McKesson (MCK) Rises Yet Lags Behind Market: Some Facts Worth Knowing

by Zacks Equity Research

McKesson (MCK) concluded the recent trading session at $511.17, signifying a +0.14% move from its prior day's close.

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

McKesson Shares Fall Following Sale of Rexall, Well.ca to Birch Hill

by Zacks Equity Research

MCK announces the sale of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, aligning with its strategy to grow oncology and biopharma services.

Stock Market News for Sep 6, 2024

by Zacks Equity Research

Markets finished mixed on Thursday as soft economic data raised concerns of a recession and doubts about whether the Fed is behind the curve on interest rate cuts.

McKesson Corporation (MCK) Is a Trending Stock: Facts to Know Before Betting on It

by Zacks Equity Research

Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

McKesson (MCK) Upgraded to Buy: Here's Why

by Zacks Equity Research

McKesson (MCK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Are Medical Stocks Lagging Atea Pharmaceuticals (AVIR) This Year?

by Zacks Equity Research

Here is how Atea Pharmaceuticals, Inc. (AVIR) and McKesson (MCK) have performed compared to their sector so far this year.

Should Value Investors Buy McKesson (MCK) Stock?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Wall Street Analysts See McKesson (MCK) as a Buy: Should You Invest?

by Zacks Equity Research

According to the average brokerage recommendation (ABR), one should invest in McKesson (MCK). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Is American Century U.S. Quality Value ETF (VALQ) a Strong ETF Right Now?

by Zacks Equity Research

Smart Beta ETF report for VALQ

MCK Stock's Uptrend Likely to Continue After Core Ventures Acquisition

by Zacks Equity Research

McKesson's agreement to acquire a controlling interest will likely bring advanced treatments and improved care experiences to patients.

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Harshit Gupta headshot

McKesson (MCK) Stock Gains 18% YTD: What's Driving the Rally?

by Harshit Gupta

McKesson's (MCK) shares rally on the back of solid fundamentals. Increasing volumes of prescription and specialty drugs boost the top line.

McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know

by Zacks Equity Research

Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

McKesson (MCK) Q1 Earnings Beat Estimates, Revenues Up Y/Y

by Zacks Equity Research

McKesson's (MCK) first-quarter fiscal 2025 results showcase growth in the U.S. Pharmaceutical segment. However, Medical Surgical Solutions suffers due to lower COVID-related sales.

McKesson (MCK) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

Although the revenue and EPS for McKesson (MCK) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

McKesson (MCK) Tops Q1 Earnings Estimates

by Zacks Equity Research

McKesson (MCK) delivered earnings and revenue surprises of 10.06% and 4.72%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Here's Why McKesson (MCK) is a Strong Momentum Stock

by Zacks Equity Research

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Henry Schein (HSIC) Q2 Earnings Beat Estimates

by Zacks Equity Research

Henry Schein (HSIC) delivered earnings and revenue surprises of 0.82% and 4.33%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?

Should You Buy, Sell or Hold McKesson (MCK) Before Q1 Earnings?

by Zacks Equity Research

McKesson's (MCK) first-quarter fiscal 2025 results are likely to reflect the solid display by the U.S. Pharmaceutical and Specialty Solutions segment, driven by higher prescription volume.

Unlocking Q1 Potential of McKesson (MCK): Exploring Wall Street Estimates for Key Metrics

by Zacks Equity Research

Beyond analysts' top -and-bottom-line estimates for McKesson (MCK), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2024.

McKesson (MCK) Advances While Market Declines: Some Information for Investors

by Zacks Equity Research

McKesson (MCK) reachead $629.09 at the closing of the latest trading day, reflecting a +1.96% change compared to its last close.

McKesson (MCK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

McKesson (MCK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

by Zacks Equity Research

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.